Celularity Inc.
General ticker "CELU" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $49.5M (TTM average)
Celularity Inc. follows the US Stock Market performance with the rate: 26.9%.
Estimated limits based on current volatility of 2.8%: low 1.98$, high 2.09$
Factors to consider:
- Earnings expected soon, date: 2025-12-05 bmo
- Total employees count: 127 (-43.6%) as of 2023
- Top business risk factors: Economic downturns and volatility, Liquidity and credit risks, Pandemic risks, Labor/talent shortage/retention, Supply chain disruptions
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.39$, 4.17$]
- 2025-12-31 to 2026-12-31 estimated range: [1.24$, 3.70$]
Financial Metrics affecting the CELU estimates:
- Positive: with PPE of 1.2 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -13.24 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: Shareholder equity ratio, % of 6.66 <= 18.93
- Negative: negative Net income
Short-term CELU quotes
Long-term CELU plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $17.98MM | $22.77MM | $54.22MM |
| Operating Expenses | $43.58MM | $215.06MM | $92.58MM |
| Operating Income | $-25.60MM | $-192.29MM | $-38.36MM |
| Non-Operating Income | $39.80MM | $-4.00MM | $-19.53MM |
| Interest Expense | $0.00MM | $3.02MM | $6.26MM |
| R&D Expense | $78.36MM | $30.46MM | $17.39MM |
| Income(Loss) | $14.21MM | $-196.28MM | $-57.89MM |
| Taxes | $0.01MM | $0.01MM | $0.00MM |
| Profit(Loss)* | $14.19MM | $-196.29MM | $-57.89MM |
| Stockholders Equity | $198.90MM | $40.96MM | $8.84MM |
| Assets | $401.07MM | $143.89MM | $132.68MM |
| Operating Cash Flow | $-137.88MM | $-38.69MM | $-6.40MM |
| Capital expenditure | $5.24MM | $4.05MM | $0.16MM |
| Investing Cash Flow | $-5.24MM | $-4.05MM | $0.51MM |
| Financing Cash Flow | $119.84MM | $24.09MM | $6.70MM |
| Earnings Per Share** | $1.01 | $-11.02 | $-2.64 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.